PubMed · 1975 · 54 citations · 8 references
MedicineNephrologyPathologyRenal PathologyRenal PathophysiologyRenal PharmacotherapyAnticoagulation In Kidney DiseaseGlomerular PathophysiologyNephrotoxicity MechanismsRenal DiseaseRenal Dose ModificationRenal ToxicityAnticoagulant PharmacologyNephrotoxic InjuryNephrotoxicity Mitigation
The protective effects of anticoagulants in nephrotoxic nephritis in rabbits have been studied, using various doses of heparin and defibrination with ancrod. Massive doses of heparin (2000 units/kg/day) were required before significant reduction in glomerular fibrin deposition, extracepillary cell proliferation and urea retention occurred. Doses of 300 and 1000 units/kg/day were insufficient to modify fibrin deposition and cell proliferation. Defibrination with ancrod provided protection, judged by histological and functional criteria, comparable to 2000 units of heparin/kg/day; but fibrin could still be demonstrated in the glomeruli of animals treated with 2000 units of heparin/kg/day, contrasting with the virtual absence of fibrin in animals given ancrod.
8
PROLONGED COAGULATION DEFECT (DEFIBRINATION SYNDROME) IN MALAYAN VIPER BITE
H. A. Reid, K.E. Chan, P. C. Thean · The Lancet · 1963 · 215 citations
Medicine, Hematology, Hemostasis +10
THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS.
P Vassalli, Robert T. McCluskey · PubMed · 1964 · 199 citations
Medicine, Nephrology, Pathology +11
ANTICOAGULANTS IN "IRREVERSIBLE" ACUTE RENAL FAILURE
Priscilla Kincaid‐Smith, B. M. Saker, K. F. Fairley · The Lancet · 1968 · 168 citations
Protective Action of Heparin in Experimental Immune Nephritis
B Halpern, P Milliez, G Lagrue et al. · Nature · 1965 · 91 citations
Medicine, Immunology, Pathology +14